BioCel Influenza Genotyping
Researchers at Los Alamos national Laboratories, UCLA, and Agilent's Automation Solutions designed and built the BioCel System for rapid characterization of pathogens, for example, the Influenza A (H1N1) virus.
The new system can sequence 10,000 or more influenza viruses per year and double shift and multiply throughput in pandemic mode (limit number of sequenced genes).
The automatic genetic sequencing of viruses can process a large number of samples, more efficiently, rapidly and reliably. Faster viral strain identification provides more time for implementation of mitigation and containment strategies.
BioCel Components
Agilent Devices:
- VWorks scheduling software
- 2 Robots
- 2 Bravo Liquid Handlers
- 2 Vertical Pipetting Stations
- 2x electro-magnetic pads each
- 2 PlateLoc Microplate Sealers
- 2 Microplate Seal Piercers
- Plate Centrifuge
- Translator
Third-Party Devices:
- 10 BioRad Dyad with 20 Thermal Cycler Docks
- Microserve plate stacker
- 4C Liconic automated incubator
- -20C Liconic automated incubator
- Mecour Chilled Plate Hotel
- Mecour Chilled Bravo Pads
BioCel PCR Viral Genotyping Process
Enlarge
Throughput:
- 40 RNA samples across 192 genes in 11 hours
- Scalable capacity to increase sample number
|